CA Patent

CA2501611A1 — 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors

Assigned to AstraZeneca AB · Expires 2004-04-22 · 22y expired

What this patent protects

The use of a compound of formula (I) in the manufacture of a medicament for use in the inhibition of 11.beta.HSD1 is described.

USPTO Abstract

The use of a compound of formula (I) in the manufacture of a medicament for use in the inhibition of 11.beta.HSD1 is described.

Drugs covered by this patent

Patent Metadata

Patent number
CA2501611A1
Jurisdiction
CA
Classification
—
Expires
2004-04-22
Drug substance claim
No
Drug product claim
No
Assignee
AstraZeneca AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.